|
1
|
Ahlborg HG, Rosengren BE, Järvinen TL,
Rogmark C, Nilsson JA, Sernbo I and Karlsson MK: Prevalence of
osteoporosis and incidence of hip fracture in women-secular trends
over 30 years. BMC Musculoskelet Disord. 11:482010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baccaro LF, Conde DM, Costa-Paiva L and
Pinto-Neto AM: The epidemiology and management of postmenopausal
osteoporosis: A viewpoint from Brazil. Clin Interv Aging.
10:583–591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Syed FA and Ng AC: The pathophysiology of
the aging skeleton. Curr Osteoporos Rep. 8:235–240. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xue F, Wagman RB, Yue S, Smith S, Arora T,
Curtis JR, Ehrenstein V, Sørensen HT, Tell G, Kieler H, et al:
Incidence rate of potential osteonecrosis of the jaw among women
with postmenopausal osteoporosis treated with prolia or
bisphosphonates: Abstract number 348. Arthritis Rheum. 67:492–495.
2015.
|
|
5
|
Montalcini T, Romeo S, Ferro Y, Migliaccio
V, Gazzaruso C and Pujia A: Osteoporosis in chronic inflammatory
disease: The role of malnutrition. Endocrine. 43:59–64. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao R: Immune regulation of osteoclast
function in postmenopausal osteoporosis: A critical
interdisciplinary perspective. Int J Med Sci. 9:825–832. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zaidi M: Skeletal remodeling in health and
disease. Nat Med. 13:791–801. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beaupre LA, Majumdar SR, Dieleman S, Au A
and Morrish DW: Diagnosis and treatment of osteoporosis before and
after admission to long-term care institutions. Osteoporos Int.
23:573–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Y, An JJ, Tabys D, Xie YD, Zhao TY, Ren
HW and Liu N: Effect of lactoferrin on the expression profiles of
long non-coding RNA during osteogenic differentiation of bone
marrow mesenchymal stem cells. Int J Mol Sci. 20:48342019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yoon JH, Abdelmohsen K and Gorospe M:
Posttranscriptional gene regulation by long noncoding RNA. J Mol
Biol. 425:3723–3730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jarroux J, Morillon A and Pinskaya M:
History, discovery, and classification of lncRNAs. Adv Exp Med
Biol. 1008:1–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao J: The functional role of long
non-coding RNAs and epigenetics. Biol Proced Online. 16:112014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin D, Wu X, Yu H, Jiang L, Zhou P, Yao X,
Meng J, Wang L, Zhang M and Zhang Y: Systematic analysis of
lncRNAs, mRNAs, circRNAs and miRNAs in patients with postmenopausal
osteoporosis. Am J Transl Res. 10:1498–1510. 2018.PubMed/NCBI
|
|
16
|
Zhang N, Hu X, He S, Ding W, Wang F, Zhao
Y and Huang Z: lncRNA MSC-AS1 promotes osteogenic differentiation
and alleviates osteoporosis through sponging microRNA-140-5p to
upregulate BMP2. Biochem Biophys Res Commun. 519:790–796. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Q, Li Y and Zhang Y, Ma L, Lin L,
Meng J, Jiang L, Wang L, Zhou P and Zhang Y: lncRNA MEG3 inhibited
osteogenic differentiation of bone marrow mesenchymal stem cells
from postmenopausal osteoporosis by targeting miR-133a-3p. Biomed
Pharmacother. 89:1178–1186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma X, Guo Z, Gao W, Wang J, Liu Y, Gao F,
Sun S, Zhou X, Yang Z and Zheng W: lncRNA-NEF is downregulated in
postmenopausal osteoporosis and is related to course of treatment
and recurrence. J Int Med Res. 47:3299–3306. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong X, Gu PC, Xu SZ and Lin XJ: Long
non-coding RNA-DANCR in human circulating monocytes: A potential
biomarker associated with postmenopausal osteoporosis. Biosci
Biotechnol Biochem. 79:732–737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu L and Xu PC: Downregulated lncRNA-ANCR
promotes osteoblast differentiation by targeting EZH2 and
regulating Runx2 expression. Biochem Biophys Res Commun.
432:612–617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai N, Li C and Wang F: Silencing of
lncRNA-ANCR promotes the osteogenesis of osteoblast cells in
postmenopausal osteoporosis via targeting EZH2 and RUNX2. Yonsei
Med J. 60:751–759. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakamura Y, Takahashi N, Kakegawa E,
Yoshida K, Ito Y, Kayano H, Niitsu N, Jinnai I and Bessho M: The
GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a
result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer
Genet Cytogenet. 182:144–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song J, Ahn C, Chun CH and Jin EJ: A long
non-coding RNA, GAS5, plays a critical role in the regulation of
miR-21 during osteoarthritis. J Orthop Res. 32:1628–1635. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng J, Wang JX and Li CH: lncRNA GAS5
overexpression alleviates the development of osteoporosis through
promoting osteogenic differentiation of MSCs via targeting
microRNA-498 to regulate RUNX2. Eur Rev Med Pharmacol Sci.
23:7757–7765. 2019.PubMed/NCBI
|
|
25
|
Saliminejad K, Khorram Khorshid HR,
Soleymani Fard S and Ghaffari SH: An overview of microRNAs:
Biology, functions, therapeutics, and analysis methods. J Cell
Physiol. 234:5451–5465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang C, He H, Wang L, Jiang Y and Xu Y:
Reduced miR-144-3p expression in serum and bone mediates
osteoporosis pathogenesis by targeting RANK. Biochem Cell Biol.
96:627–635. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu Z, Zhang L, Wang H, Wang Y, Tan Y, Dang
L, Wang K, Sun Z, Li G, Cao X, et al: Targeted silencing of
miRNA-132-3p expression rescues disuse osteopenia by promoting
mesenchymal stem cell osteogenic differentiation and osteogenesis
in mice. Stem Cell Res Ther. 11:582020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Yi X, Tu S, Cheng C and Luo J:
Kaempferol promotes BMSC osteogenic differentiation and improves
osteoporosis by downregulating miR-10a-3p and upregulating CXCL12.
Mol Cell Endocrinol. 520:1110742021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu R, Lv WC, Xu Y, Gong MY, Chen XJ, Jiang
N, Xu Y, Yao QQ, Di L, Lu T, et al: Endothelial ZEB1 promotes
angiogenesis-dependent bone formation and reverses osteoporosis.
Nat Commun. 11:4602020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang M, Li CJ, Sun X, Guo Q, Xiao Y, Su T,
Tu ML, Peng H, Lu Q, Liu Q, et al: miR-497~195 cluster regulates
angiogenesis during coupling with osteogenesis by maintaining
endothelial Notch and HIF-1α activity. Nat Commun. 8:160032017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deckers MM, Karperien M, van der Bent C,
Yamashita T, Papapoulos SE and Löwik CW: Expression of vascular
endothelial growth factors and their receptors during osteoblast
differentiation. Endocrinology. 141:1667–1674. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ensrud KE and Crandall CJ: Osteoporosis.
Ann Intern Med. 167:ITC17–ITC32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li H, Xiao Z, Quarles LD and Li W:
Osteoporosis: Mechanism, molecular target, and current status on
drug development. Curr Med Chem. 28:1489–1507. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Compston J: Practical guidance for the use
of bisphosphonates in osteoporosis. Bone. 25:1153302020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang H, Mo S, Yang L, Wang P, Sun K, Xiong
Y, Liu H, Liu X, Wu Z, Ou L, et al: Effectiveness associated with
different therapies for senile osteoporosis: A network
meta-analysis. J Tradit Chin Med. 40:17–27. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Zhao D, Zhu Y, Dong Y and Liu Y:
Long non-coding RNA GAS5 promotes osteogenic differentiation of
bone marrow mesenchymal stem cells by regulating the
miR-135a-5p/FOXO1 pathway. Mol Cell Endocrinol. 496:1105342019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Z, Zhang W and Huang Y: miRNA-133a is
involved in the regulation of postmenopausal osteoporosis through
promoting osteoclast differentiation. Acta Biochim Biophys Sin
(Shanghai). 50:273–280. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ismail SM, El Boghdady NA, Hamoud HS and
Shabayek MI: Evaluation of circulating miRNA-208a-3p, miRNA-155-5p
and miRNA-637 as potential non-invasive biomarkers and the possible
mechanistic insights into pre- and postmenopausal osteoporotic
females. Arch Biochem Biophys. 684:1083312020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xiaoling G, Shuaibin L and Kailu L:
MicroRNA-19b-3p promotes cell proliferation and osteogenic
differentiation of BMSCs by interacting with lncRNA H19. BMC Med
Genet. 21:112020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Meng YC, Lin T, Jiang H, Zhang Z, Shu L,
Yin J, Ma X, Wang C, Gao R and Zhou XH: miR-122 exerts inhibitory
effects on osteoblast proliferation/differentiation in osteoporosis
by activating the PCP4-mediated JNK pathway. Mol Ther Nucleic
Acids. 20:345–358. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu TJ and Guo JL: Overexpression of
microRNA-141 inhibits osteoporosis in the jawbones of
ovariectomized rats by regulating the Wnt/β-catenin pathway. Arch
Oral Biol. 113:1047132020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fu Y, Xu Y, Chen S, Ouyang Y and Sun G:
miR-151a-3p promotes postmenopausal osteoporosis by targeting SOCS5
and activating JAK2/STAT3 signaling. Rejuvenation Res. 23:313–323.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang T, Zhang C, Wu C, Liu J, Yu H, Zhou
X, Zhang J, Wang X, He S, Xu X, et al: miR-765 inhibits the
osteogenic differentiation of human bone marrow mesenchymal stem
cells by targeting BMP6 via regulating the BMP6/Smad1/5/9 signaling
pathway. Stem Cell Res Ther. 11:622020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee HS and Park T: Nuclear receptor and
VEGF pathways for gene-blood lead interactions, on bone mineral
density, in Korean smokers. PLoS One. 13:e01933232018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lane NE: Epidemiology, etiology, and
diagnosis of osteoporosis. Am J Obstet Gynecol. 194 (Suppl
2):S3–S11. 2006. View Article : Google Scholar : PubMed/NCBI
|
